Mucormycosis

Endocrine Emergencies: Recognition and Treatment

Volumn , Issue , 2014, Pages 57-63

  Doggett, J Stone ^a   Wong, Brian ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84992184633     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-62703-697-9_6     Document Type: Chapter

References (12)

1. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634-53.
2. Skiada A, Pagano L, Groll A, et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect. 2011;17(12):1859-67.
3. Chakrabarti A, Das A, Mandal J, et al. The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Med Mycol. 2006;44(4):335-42.
4. Bitar D, Van Cauteren D, Lanternier F, et al. Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006. Emerg Infect Dis. Sep 2009;15(9):1395-401.
5. Kontoyiannis DP, Lewis RE, editors. Agents of mucormycosis and entomophthoramycosis. In:Mandell, Douglas, and Bennett's principles and practice of infectious diseases, No. 2. 7th ed. Philadelphia, PA: Churchill Livingstone Elsevier; 2010.
6. Ibrahim AS, Gebremariam T, Lin L, et al. The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis. Mol Microbiol. Aug 2010;77(3):587-604.
7. Speert DP, Silva Jr J. Abnormalities of in vitro lymphocyte response to mitogens in diabetic children during acute ketoacidosis. Am J Dis Child. Oct 1978;132(10):1014-7.
8. Yohai RA, Bullock JD, Aziz AA, Markert RJ. Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol. 1994;39(1):3-22.
9. Sun HY, Singh N. Mucormycosis: its contemporary face and management strategies. Lancet Infect Dis. Apr 2011;11(4):301-11.
10. van Burik JA, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DP. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis. 2006;42(7):e61-5.
11. Reed C, Bryant R, Ibrahim AS, et al. Combination polyene-caspofungin treatment of rhinoorbital-cerebral mucormycosis. Clin Infect Dis. 2008;47(3):364-71.
12. Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis. 2008;47(4):503-9.